Biotechnology Business Investment Opportunity in Manlius, United States

Our company is seeking an investor or partner for the marketing of our in vitro human reproductive and developmental toxicology screening system that uses human umbilical cord & placenta stem cells instead of animals. We are also developing non-animal 3-D printed cell culture systems representative of various normal and compromised human tissue microenvironments including chronic conditions associated with aging, kidney disease, and oncology to meet the needs of pharmaceutical and biopharmaceutical companies in target discovery, drug efficacy testing, and drug safety. Our 3D tissue constructs, or patient samples, can also be viewed using virtual reality (VR) tools. For example, using VR, detailed examinations of human melanoma by clinicians can be made, and disease progression or possible treatments determined based on these details. Patients themselves can also immerse themselves in the VR space and view their VR images using our tools. The system may also be used by pharmaceutical companies to conduct clinical trials and translate lab discoveries into real-life personalized medicine applications using VR tools.